Division of Surgical Oncology, Department of Surgery, University of Pittsburgh Medical Center, 5150 Centre Ave., Suite 420, Pittsburgh, PA 15232, USA.
Surg Endosc. 2013 Feb;27(2):587-92. doi: 10.1007/s00464-012-2494-y. Epub 2012 Aug 31.
Since first being described in 2009, single-incision laparoscopic splenectomy has been described in a limited number of case reports and small case series. No studies have evaluated single-incision splenectomy in unselected patients, and outcomes of the procedure have not previously been compared to standard laparoscopy.
A retrospective review was conducted to evaluate all single-incision splenectomies performed by a single surgeon between June 2010 and June 2011. Additionally, patients who underwent standard laparoscopic splenectomy by surgeons in the same tertiary referral surgical oncology group were evaluated to serve as a control group. Demographic data, operative parameters, and postoperative outcomes were assessed.
Eight patients underwent successful single-incision splenectomy during the study period without conversion to an open procedure or requiring additional ports. The median operative time was 92.5 min. There was 25 % morbidity and no mortality in the study group. Median length of stay was 4 days. Additionally, 18 patients who underwent standard laparoscopic splenectomy were evaluated for comparison. No significant differences were identified in the preoperative patient characteristics between the two groups. Single-incision splenectomy was associated with a shorter operative time (92.5 vs. 172 min, p = 0.003), lower conversion rate, equivalent length of stay, reduced mortality, similar morbidity, and comparable postoperative narcotic requirements.
Single-incision splenectomy is feasible, safe, and efficient in an unselected patient population in the hands of an experienced laparoscopic surgeon. The single-incision technique is comparable to standard laparoscopic splenectomy in terms of operative time and perioperative outcomes.
自 2009 年首次描述以来,单切口腹腔镜脾切除术已在有限数量的病例报告和小系列病例中得到描述。没有研究评估过单切口脾切除术在未选择的患者中的应用,并且该手术的结果以前也没有与标准腹腔镜进行比较。
对一位外科医生在 2010 年 6 月至 2011 年 6 月期间进行的所有单切口脾切除术进行回顾性分析。此外,评估了同一三级转诊外科肿瘤组的外科医生进行的标准腹腔镜脾切除术的患者作为对照组。评估了人口统计学数据、手术参数和术后结果。
在研究期间,8 例患者成功完成了单切口脾切除术,没有转为开放手术或需要额外的端口。中位手术时间为 92.5 分钟。研究组的发病率为 25%,无死亡率。中位住院时间为 4 天。此外,还评估了 18 例接受标准腹腔镜脾切除术的患者进行比较。两组患者术前特征无显著差异。单切口脾切除术与较短的手术时间(92.5 分钟比 172 分钟,p=0.003)、较低的转化率、相当的住院时间、降低的死亡率、相似的发病率和可比的术后麻醉需求相关。
在有经验的腹腔镜外科医生手中,单切口脾切除术在未选择的患者人群中是可行、安全和有效的。单切口技术在手术时间和围手术期结果方面与标准腹腔镜脾切除术相当。